These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4371221)

  • 41. Auxological and biochemical parameters in assessing treatment of infants and toddlers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Einaudi S; Lala R; Corrias A; Matarazzo P; Pagliardini S; de Sanctis C
    J Pediatr Endocrinol; 1993; 6(2):173-8. PubMed ID: 8348221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neonatal screening for congenital adrenal hyperplasia using 17-hydroxyprogesterone assay in filter paper blood spots.
    Larsson A; Hagenfeldt L; von Döbeln U; Curstedt T; Gustafsson J; Svensson E
    Horm Res; 1988; 30(6):235-40. PubMed ID: 3250925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early diagnosis of congenital adrenal hyperplasia by measurement of 17-hydroxyprogesterone.
    Youssefnejadian E; David R
    Clin Endocrinol (Oxf); 1975 Jul; 4(4):451-54. PubMed ID: 168994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Congenital adrenal hyperplasia.
    Newns GH
    Arch Dis Child; 1974 Jan; 49(1):1-3. PubMed ID: 4361888
    [No Abstract]   [Full Text] [Related]  

  • 45. [Current aspects of the diagnosis and treatment in congenital dysfunction of the adrenal cortex in children].
    Kuznetsova ES
    Pediatriia; 1989; (11):32-8. PubMed ID: 2608370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Plasma 17-alpha-hydroxyprogesterone concentration for the diagnosis of congenital adrenal hyperplasia (author's transl)].
    Dumić M; Kalafatić Z; Tajić M; Gjurić G; Mardesić D
    Lijec Vjesn; 1980; 102(7-8):400-3. PubMed ID: 7289713
    [No Abstract]   [Full Text] [Related]  

  • 47. [17-hydroxyprogesterone, testosterone and androstenedione in treated congenital adrenogenital syndrome].
    von Schnakenburg K; Bidingmaier F; Knorr D
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):579-80. PubMed ID: 876244
    [No Abstract]   [Full Text] [Related]  

  • 48. Plasma adrenocorticotrophic hormone in congenital adrenal hyperplasia. Importance in long-term management.
    LaFranchi S
    Am J Dis Child; 1980 Nov; 134(11):1068-72. PubMed ID: 6254355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of menstrual irregularities with dexamethasone in congenital adrenal hyperplasia.
    Granoff AB
    J Adolesc Health Care; 1981 Sep; 2(1):23-7. PubMed ID: 7333940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary 17 alpha-hydroxyprogesterone in management of 21-hydroxylase deficiency.
    Lim YJ; Yong AB; Warne GL; Montalto J
    J Paediatr Child Health; 1995 Feb; 31(1):47-50. PubMed ID: 7748691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pregnenolone, 17-OH-pregnenolone, and testosterone in plasma of patients with congenital adrenal hyperplasia.
    McKenna TJ; Jennings AS; Liddle GW; Burr IM
    J Clin Endocrinol Metab; 1976 May; 42(5):918-25. PubMed ID: 178685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood-spot 17 alpha-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia.
    Sólyom J
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):547-53. PubMed ID: 7296904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
    Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L
    J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O; Shimura N; Nakayama Y; Arisaka M; Yabuta K
    Dtsch Med Wochenschr; 1988 Dec; 113(49):1913-5. PubMed ID: 3197614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum 3 alpha-androstanediol glucuronide measurements in children with congenital adrenal hyperplasia.
    Hatun S; Yordam N; Calikoğlu AS
    Eur J Endocrinol; 1994 Nov; 131(5):504-8. PubMed ID: 7952161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.
    Sólyom J
    Arch Dis Child; 1984 Aug; 59(8):743-7. PubMed ID: 6541026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma renin activity in the management of congenital adrenal hyperplasia.
    Griffiths KD; Anderson JM; Rudd BT; Virdi NK; Holder G; Rayner PH
    Arch Dis Child; 1984 Apr; 59(4):360-5. PubMed ID: 6372706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 17-Hydroxyprogesterone rhythms and growth velocity in congenital adrenal hyperplasia.
    Pincus DR; Kelnar CJ; Wallace AM
    J Paediatr Child Health; 1993 Aug; 29(4):302-4. PubMed ID: 8373678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimation of 17 alpha-hydroxyprogesterone in dried blood spots for mass screening of newborn infants with congenital adrenal hyperplasia.
    Mardesić D; Dumić M; Tajić M; Gjurić G; Letica-Protega N
    Acta Med Iugosl; 1983; 37(2):95-100. PubMed ID: 6880831
    [No Abstract]   [Full Text] [Related]  

  • 60. 125I radioimmunoassay for 17 alpha-hydroxyprogesterone in plasma, for diagnosing and managing congenital adrenal hyperplasia.
    Yeo KH; Whitau WJ
    Clin Chem; 1985 Mar; 31(3):454-6. PubMed ID: 3971567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.